Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean Dormont is active.

Publication


Featured researches published by Jean Dormont.


Journal of Clinical Psychology | 1999

Disclosure of HIV seropositivity

Agnès Lévy; Francine Laska; Alain Abelhauser; Jean-François Delfraissy; Cécile Goujard; François Boué; Jean Dormont

Deciding whether or not to disclose ones HIV-positive status to another person is an important decision: the way each person experiences and copes with the illness is reflected in this choice. We conducted a study of 174 patients (29.3% of women) to examine how the decision to disclose or conceal was made, as well as its subjective and social consequences. We discovered that only 3.5% of the individuals remained silent about their illness. Most spoke about it, regardless of how they had been infected or of the advice they had received to be discrete. The confession often did not bring them the relief they sought. Revealing ones HIV-positive status is not a sign of social responsibility, or of a special trust in someone, but rather a compulsive act to release suppressed tension. Individuals who do not confess need attention; their silence is a sign of their inability to adapt to their illness, as well as of their self-imposed exclusion from society.


European Journal of Clinical Investigation | 1981

Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarction.

François G. Brivet; Jean-François Delfraissy; Jean-François Giudicelli; Christine Richer; Alain Legrand; Jean Dormont

Abstract. In eight patients with acute left ventricular failure secondary to myocardial infarction the haemo‐dynamic effects of captopril (25 mg), an orally active converting enzyme inhibitor, were measured. Haemo‐dynamic modifications were maximal at 60 min and lasted for 2–3 h. Pulmonary wedge pressure fell from 23–5± 4.9(mean ± SD)to 16–8 ± 4.7 mmHg(P<0–01), cardiac output rose from 3–24 ± 1 to 4–05 ± 0–91 1/min (P<001). Systemic vascular resistance decreased from 27–34 ± 3–81 to 17.52 ± 1–65 mmHg min 1‐1 (P<001). Mean arterial pressure fell from 89.6 ± 13.9 to 75.7±0 16.3 mmHg (P<0001) while heart rate was not significantly modified. Six patients who had high pretreatment plasma renin activity values responded by a decrease in ventricular filling pressure and/or an increase in cardiac output. One patient with normal initial plasma renin activity value showed similar haemodynamic effects. These data suggest that in the short term captopril is a vasodilator with both arterial and venous effects and improves cardiac function in acute left ventricular failure secondary to myocardial infarction.


Baillière's clinical endocrinology and metabolism | 1994

10 Pancreatic lesions in HIV-infected patients

François G. Brivet; Sylvie Naveau; Guy Lemaigre; Jean Dormont

The pancreas is frequently involved during HIV infection, especially by disseminated infections or neoplasms. These lesions are generally asymptomatic and are discovered at autopsy. However, hypoglycaemia secondary to massive pancreatic infiltration by a tumour or tuberculous necrosis may occur. The most important cause of pancreatic dysfunction in HIV-infected patients is a drug toxic effect (intravenous pentamidine, didanosine, zalcitabine). Hypoglycaemia, which may or may not be followed by diabetes, can develop during intravenous pentamidine therapy. In cases with increased serum amylase and/or lipase levels, potentially toxic drugs must be promptly discontinued to avoid major pancreatic involvement.


Kidney International | 1984

Captopril and immune regulation.

Jean-François Delfraissy; Pierre Galanaud; Jean-François Balavoine; Christine Wallon; Jean Dormont


Journal of Immunology | 1978

Primary in Vitro Antibody Response of Human Peripheral Blood Lymphocytes: Role of Phagocytic Mononuclear Cells

Jean-François Delfraissy; Pierre Galanaud; Jean Dormont; Christine Wallon


Cancer Chemotherapy and Pharmacology | 1986

Inefficiency of early prophylactic hemodialysis in cis-platinum overdose

François G. Brivet; Jean-Marc Pavlovitch; Alain Gouyette; Marie-Lise Cerrina; Gil Tchernia; Jean Dormont


Critical Care Medicine | 1994

Hypothermia, a pertinent clinical prognostic factor in severe systemic inflammatory response syndrome.

François G. Brivet; Pierre Marie Carras; Jean Dormont; Bertrand Gidet; Georges Offenstadt; Gachot; Michel Wolf; Benoit Misset


Clinical Infectious Diseases | 1994

Pasteurella multocida Sepsis After Hemorrhagic Shock in a Cirrhotic Patient: Possible Role of Endoscopic Procedures and Gastrointestinal Translocation

François G. Brivet; Michèle Guibert; Philippe Barthélémy; Anne Lepicard; Sylvie Naveau; Jean Dormont


Critical Care Medicine | 1990

Limitations of Intensive Procedures in Cirrhotic Patients with Liver Failure

François G. Brivet; Naveau S; Jean Dormont; Chaput Jc


Clinical Infectious Diseases | 1995

Failure of the Radiometric Bactec Method to Detect Mycobacterium avium Complex in the Blood of Patients Infected with Human Immunodeficiency Virus Who Were Treated with Antibiotics

Léa Lebrun; Joël Livartowski; Thierry May; Jean Dormont; Patrice Nordmann

Collaboration


Dive into the Jean Dormont's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Benoit Misset

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge